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The treatment of knee osteoarthritis: a review of current 
evidence-based medicine
There is confusing information in the literature concerning 
the efficacy of different types of non-operative and surgical 
treatments for osteoarthritis (OA) of the knee. This editorial has 
revised the evidence-based medicine on the management of 
OA of the knee. To get this goal the most important systematic 
reviews and randomized clinical trials published in the English 
literature have been revised.
Regarding non-operative treatment with analgesics and anti-
infl amatory drugs Kivitz, et al. did not fi nd statistically signifi cant 
diff erences in eff ectiveness and tolerability between cyclooxy-
genase-2 (COX-2) selective inhibitors and non-selective NSAIDs 
in patients with OA knee pain1. Treatment with celecoxib 200 
mg once daily and diclofenac 50 mg twice daily demonstrated 
comparable effi  cacy in relieving the signs and symptoms of OA2. 
Lumiracoxib 100 mg once daily is eff ective and well tolerated when 
treating OA pain of the knee for periods of up to 1 year, making 
it a useful option for the long-term treatment of OA pain3. Advice 
to use either oral or topical preparations has an equivalent eff ect 
on knee pain, but oral NSAIDs appear to produce more minor 
adverse eff ects than topical NSAIDs4. Older people with knee pain 
must be advised to use topical rather than oral NSAIDS. Wu, et al.5 
reported that glucosamine hydrochloride (GH) is ineff ective for 
pain reduction in patients with knee OA. Glucosamine sulphate 
(GS) showed no pain-reduction benefi ts after 6 months of therapy.
Concerning intra-articular injections of hyaluronic acid (HA) 
Colen, et al.6 reported that HA improves pain by approximately 
40-50% compared with baseline levels. Comparing the diff erent 
HA products, which vary in the molecular weight, concentration, 
and volume of HA, they were not able to conclude that one brand 
has a better effi  cacy than another due to the heterogeneity of the 
studies and outcomes. Rutjes, et al.7 showed that in patients with 
knee OA, viscosupplementation is associated with a small and 
clinically irrelevant benefi t.
Regarding rehabilitation and physiotherapy, Wang, et al.8 
reported that in patients with knee pain secondary to OA aerobic 
and aquatic exercise improve disability, and that aerobic exercise, 
strengthening exercise, and ultrasounds reduce pain and improve 
function. According to Davis and Mackay9 exercise remains a 
mainstay of conservative management although most studies 
report only short-term outcomes. Penny, et al.10 reported that there 
is limited evidence to support the prescription of lateral wedge 
insole (LWI) to people with medial compartment knee OA to 
reduce pain and increase function. A meta-analysis published by 
Parkes, et al.11 did not support the use of lateral wedges for knee 
OA. Lauche, et al.12 have reported that Tai Chi is at least short-term 
eff ective and safe it might be preliminarily recommended as an 
adjuvant treatment for patients with OA of the knee. 
Concerning surgical treatment by means of arthroscopic 
debridement, the meta-analysis reported by Spahn, et al.13 de-
monstrated that arthroscopic joint debridement is a potential and 
suffi  cient treatment for knee OA in a middle-term time interval. 
This procedure resulted in an excellent or good outcome in 
approximately 60% of patients in approximately 5 years. When 
comparing high tibial osteotomy (HTO) and unicompartmental 
knee arthroplasty (UKA), Sphan, et al.14 found HTO to be more 
appropriate for younger patients who accept a slight decrease 
in their physical activity. Medial UKA is appropriate for older pa-
tients obtaining suffi  cient pain relief but with reduced physical 
activity. Fu, et al.15 showed that UKA yielded signifi cantly better 
results compared to HTO in terms of function results, however, no 
diff erence in specifi c knee score was observed; HTO got slightly 
better results of the range of motion. Postoperative rate of revi-
sion and complications did not diff er signifi cantly between two 
groups. With the correct patient selection, both HTO and UKA 
show eff ective and reliable results. Regarding the controversy UKA 
versus total knee arthroplasty (TKA), Koskinen, et al.16 found that 
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UKA had a 60% survival rate and TKA an 80% survival rate at 15 years 
with any revision taken as the endpoint. Overall survival of UKA was 
worse than that of TKA. In the cost-benefi t analysis, the cost saved by 
lower implant prices and shorter hospital stay with UKA did not cover 
the costs of the extra revisions. UKA had signifi cantly poorer long-term 
survival than TKA. Based on these results, Koskinen, et al.16 could not 
recommend widespread use of UKA in treatment of unicompartmental 
OA of the knee. 
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